Overview
- 13 inspections across 13 sites are on record.
- 33 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-08-01.
At a glance
Inspections
13
Sites
13
Observations
33
Career since
Apr 2012
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Teva Pharmaceutical Industries | 1 Aug 2019 | Human Drugs | On file |
| Teva Pharmaceutical Industries Ltd. | 25 Jul 2019 | Human Drugs | On file |
| Apozeal Pharmaceuticals Inc. | 9 Apr 2019 | Human Drugs | View 483 → |
| Actavis Laboratories FL, Inc. | 20 Dec 2013 | Human Drugs | View 483 → |
| Nang Kuang Pharmaceutical Co. Ltd. | 30 Aug 2013 | Human Drugs | On file |
Sites inspected
Teva Pharmaceutical IndustriesJerusalem, Israel1 insp.
Teva Pharmaceutical Industries Ltd.Kfar Saba, Israel1 insp.
Apozeal Pharmaceuticals Inc.Levittown, United States1 insp.
Actavis Laboratories FL, Inc.Davie, United States1 insp.
Nang Kuang Pharmaceutical Co. Ltd.Tainan City, Taiwan1 insp.
Co-investigators
Investigators who share inspections with this person.
Barbara J Breithaupt4 shared
April L Young3 shared
Noreen Muniz2 shared
Lisa B Orr1 shared
Christina K Theodorou1 shared
Heika R Tait1 shared
Maria V Price1 shared
Dawn M Mccabe1 shared
Maria P Kelly-Doggett1 shared
Caryn M Mcnab1 shared
Full investigator report
Get the verbatim findings behind Dandan Wang's 33 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site